Caffeinated Gum to Prevent Post-Operative Ileus: A Prospective, Randomized, Placebo-controlled Trial
Not Applicable
Withdrawn
- Conditions
- C.Surgical Procedure; Digestive System
- Interventions
- Other: GumBehavioral: wear silicone braceletDietary Supplement: Caffeine
- Registration Number
- NCT02250924
- Lead Sponsor
- The Guthrie Clinic
- Brief Summary
This is a randomized, three-arm, double-blind, placebo-controlled, Phase III clinical trial of caffeinated gum and sugar-less gum in adult patients after an abdominal procedure. Patients will be randomized to receive placebo, sugar-less gum or caffeinated gum three times daily for 30 minutes starting the day following surgery until discharge or 24 hours after attainment of the primary endpoint.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Abdominal procedure (Laparoscopic or open, occurring electively), American Society of Anesthesiologists (ASA) physical status score ≤ 3, Glasgow Coma Score (GCS) ≥ 15.
Exclusion Criteria
- ASA physical status score of >3, GCS < 15, complete bowel obstruction, history of cardiac arrhythmia, history of phenylketonuria, alcohol abuse. substance abuse dentures
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Sugar-less Gum Gum Subjects will chew one stick of sugar-less gum for 30 minutes 3 times daily at 8 am, 12 pm and 4 pm. Placebo wear silicone bracelet Subjects will wear a silicone bracelet for 30 minutes 3 times daily at 8 am, 12 pm and 4 pm. Caffeinated Gum Caffeine Subjects will chew one stick of caffeinated gum (100mg caffeine per stick) for 30 minutes 3 times daily at 8 am, 12 pm and 4 pm. Caffeinated Gum Gum Subjects will chew one stick of caffeinated gum (100mg caffeine per stick) for 30 minutes 3 times daily at 8 am, 12 pm and 4 pm.
- Primary Outcome Measures
Name Time Method Mean time to GI function recovery (GI-3) An expected average of 5 days
- Secondary Outcome Measures
Name Time Method Mean length of postoperative hospitalization Up to 30 days Rate of postoperative ileus Up to 30 days Adverse event rates Up to 30 days postoperative
Trial Locations
- Locations (1)
The Guthrie Clinic
🇺🇸Sayre, Pennsylvania, United States